Shubham Thakur

Dr. Shubham Thakur

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2020 in Current Drug Metabolism
Verified
Journal Article
Closed access
PDF file
STShubham Thakur
Shubham Thakur
ASAmrinder Singh
Amrinder Singh
RSRitika Sharma
Ritika Sharma
RARohan Aurora
Rohan Aurora
SJSubheet Kumar Jain
Subheet Kumar Jain
Background: Surfactants are an important category of additives that are used widely in most of the formulations as solubilizers, stabilizers, and emulsifiers. Current drug delivery systems comprise of numerous synthetic surfactants (such as Cremophor EL, polysorbate 80, Transcutol-P), which are associated with several side effects though used in many formulations. Therefore, to attenuate the problems associated with conventional surfactants, a new generation of surface-active agents is obtained from the metabolites of fungi, yeast, and bacteria, which are termed as biosurfactants. Objectives: In this article, we critically analyze the different types of biosurfactants, their origin along with their chemical and physical properties, advantages, drawbacks, regulatory status, and detailed pharmaceutical applications. Methods: 243 papers were reviewed and included in this review. Results: Briefly, Biosurfactants are classified as glycolipids, rhamnolipids, sophorolipids, trehalolipids, surfactin, lipopeptides & lipoproteins, lichenysin, fatty acids, phospholipids, and polymeric biosurfactants. These are amphiphilic biomolecules with lipophilic and hydrophilic ends and are used as drug delivery vehicles (foaming, solubilizer, detergent, and emulsifier) in the pharmaceutical industry. Despite additives, they have some biological activity as well (anti-cancer, anti-viral, anti-microbial, P-gp inhibition, etc.). These biomolecules possess better safety profiles and are biocompatible, biodegradable, and specific at different temperatures. Conclusion: Biosurfactants exhibit good biomedicine and additive properties that can be used in developing novel drug delivery systems. However, more research should be driven due to the lack of comprehensive toxicity testing and high production cost which limits their use.

12 April 2024 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
ALAkshay Kumar Lunawat
Akshay Kumar Lunawat
STShubham Thakur
Shubham Thakur
BKBalak Das Kurmi
Balak Das Kurmi
GGGhanshyam Das Gupta
Ghanshyam Das Gupta
PPPreeti Patel
Preeti Patel
SRSarjana Raikwar
Sarjana Raikwar

18 May 2023 in Gut Pathogens
Verified
Journal Article
Open access
PDF file
MRMuzamil Rashid
Muzamil Rashid
ANAnmol Narang
Anmol Narang
STShubham Thakur
Shubham Thakur
SJSubheet Kumar Jain
Subheet Kumar Jain
SKSukhraj Kaur
Sukhraj Kaur
Salmonella enterica serotype Typhi causes chronic enteric fever known as typhoid. Prolonged treatment regimen used for the treatment of typhoid and indiscriminate use of antibiotics has led to the emergence of resistant strains of S. enterica that has further increased the severity of the disease. Therefore, alternative therapeutic agents are urgently required. In this study, probiotic and enterocin-producing bacteria Enterococcus faecium Smr18 was compared for both its prophylactic and therapeutic efficacy in S. enterica infection mouse model. E. faecium Smr18 possessed high tolerance to bile salts and simulated gastric juice, as treatment for 3 and 2 h resulted in 0.5 and 0.23 log10 reduction in the colony forming units, respectively. It exhibited 70% auto aggregation after 24 h of incubation and formed strong biofilms at both pH 5 and 7. Oral administration of E. faecium in BALB/c mice infected with S. enterica significantly (p < 0.05) reduced the mortality of the infected mice and prevented the weight loss in mice. Administration of E. faecium prior to infection inhibited the translocation of S. enterica to liver and spleen, whereas, its administration post-infection completely cleared the pathogen from the organs within 8 days. Further, in both pre- and post-E. faecium-treated infected groups, sera levels of liver enzymes were restored back to normal; whereas the levels of creatinine, urea and antioxidant enzymes were significantly (p < 0.05) reduced compared to the untreated-infected group. E. faecium Smr18 administration significantly increased the sera levels of nitrate by 1.63-fold and 3.22-fold in pre- and post-administration group, respectively. Sera levels of interferon-γ was highest (tenfold) in the untreated-infected group, whereas the levels of interleukin-10 was highest in the post-infection E. faecium-treated group thereby indicating the resolution of infection in the probiotic-treated group, plausibly due to the increased production of reactive nitrogen intermediates.

28 October 2024 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
TSTaqdir Singh
Taqdir Singh
AAAkshita Arora
Akshita Arora
KSKantrol Kumar Sahu
Kantrol Kumar Sahu
PPPreeti Patel
Preeti Patel
SKSimranjeet Kaur
Simranjeet Kaur
BKBalak Das Kurmi
Balak Das Kurmi

1 December 2023 in Journal of King Saud University – Science
Verified
Journal Article
Open access
NSNeha Sharma
Neha Sharma
STShubham Thakur
Shubham Thakur
RKRasdeep Kour
Rasdeep Kour
DEDeepika
Deepika
AKAjay Kumar
Ajay Kumar
SKSatwinderjeet Kaur
Satwinderjeet Kaur

3 May 2024 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
NSNavid Reza Shahtaghi
Navid Reza Shahtaghi
SBSamira Bigdelitabar
Samira Bigdelitabar
STShubham Thakur
Shubham Thakur
MKManjot Kaur
Manjot Kaur
HSHarjeet Singh
Harjeet Singh
SJSubheet Kumar Jain
Subheet Kumar Jain